Editorial: Blood pressure variability: Emerging role in risk assessment and therapeutics

Blood Pressure

Volumn 19, Issue 4, 2010, Pages 209-211

  Oparil, Suzanne ^a   Kjeldsen, Sverre E ^b   Narkiewicz, Krzysztof ^c   Hedner, Thomas ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EDITORIAL; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSE PRESSURE; RISK ASSESSMENT; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; BLOOD PRESSURE; CONFERENCE PAPER; PHYSIOLOGY;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; RISK ASSESSMENT;

EID: 77955312357     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2010.510279     Document Type: Editorial

References (25)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
3. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:934-948.
4. Klungel OH, de Boer A, Paes AH, Nagelkerke NJ, Seidell JC, Bakker A. Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. J Clin Epidemiol. 2000;53:1158-1163.
5. Turner MJ, van Schalkwyk JM. Blood pressure variability causes spurious identification of hypertension in clinical studies: a computer simulation study. Am J Hypertens. 2008;21:85-91.
6. Marshall T. When measurements are misleading: modeling the effects of blood pressure misclassification in the English population. BMJ. 2004;328:933.
7. Keenan K, Hayen A, Neal BC, Irwig L. Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. BMJ. 2009;338:b1492.
8. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716.
9. OBrien E, Asmar R, Beilin L, Imai Y, Giuseppe M, Mengden T, et al. On behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697-701.
10. Rothwell PM, Howard SC, Dolan E, OBrien E, Dobson JE, Dahl ö f B, et al. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9469-9480
11. Howard SC, Rothwell PM. Regression dilution of systolic and diastolic blood pressure in patients with established cerebrovascular disease. J Clin Epidemiol. 2003;56:1084-1091.
12. Cuffe R, Howard SC, Algra A, Warlow CP, Rothwell PM. Medium-term variability of blood pressure and potential under-diagnosis of hypertension in patients with previous transient ischaemic attack or minor stroke. Stroke. 2006;37: 2776-2783.
13. Howard SC, Rothwell PM. Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke. Cerebrovasc Dis. 2009;28: 331-340.
14. Cuffe RL, Rothwell PM. Medium-term variability in systolic blood pressure is an independent predictor of stroke. Cerebrovasc Dis. 2005;19(suppl 2):51.
15. Rothwell PM, Howard SC, Dolan E, O B rien E, Dobson JE, Dahl ö f B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
16. Dahlö f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906.
17. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
18. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54: 1044-1054.
19. Poulter NR, Wedel H, Dahlö f B, for the ASCOT investigators, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo- Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005;366:907-913.
20. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and metaanalysis. Lancet. 2010;375:906-915.
21. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983;53:96-104.
22. Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation. 2000:102:1536-1541.
23. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension. 2002;39(Pt 2):710-714.
24. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-1783.
25. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Longterm risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846-853.